Why GLP-1 Medications Can Change the Appearance of Your Skin GLP-1 medications work by reducing appetite and slowing digestion, helping patients lose weight more efficiently
In Phase 2 trials over 48 weeks, participants at the 12mg dose achieved an average of 24.2% body weight reduction, outpacing both Semaglutide (14.9%) and Tirzepatide (20.9%) in comparative data
Long-term outcome data will ultimately determine these compounds place in obesity treatment
This is also probably a combination of glucagon and GIP agonism contributing to changes in certain background proteins, specifically lipoprotein lipase, ANGPTL 3 / 8 complexes and ApoC3 as shown in other studies
Retatrutide reportedly had a similar "tolerability profile" to tirzepatide, according to endocrinologist Dr Scott Isaacs, an obesity medicine specialist and faculty at Emory Medical School in Georgia, US
This calculator helps estimate mL, units, doses per vial, and weeks of medication based on concentration and dose
![PDF] Evidence that Increased Acetaminophen use in Genetically Vulnerable Children Appears to be a Major Cause of the Epidemics of Autism, Attention Deficit with Hyperactivity, and Asthma](https://figures.semanticscholar.org/25b1d7810b4665714beec7d74a4ae4b6cbfa4022/6-Figure2-1.png)
